Unreliable Antidepressant drug literature

Facebooktwittergoogle_plusredditpinterestlinkedinmail

HealthThe antidepressant drug Cymbalta is among the many highly publicized remedies/reliefs for clinical, debilitating depression. In an article written in 2005 titled A Cure Worse Than the Disease by Baum Hedlund, the author cites examples of suicides in the low teen age range and a Prozac crazed 13 year old who stabbed his Aunt to death.

Hedlund reveals that the big pharmaceuticals are much less likely to publish the outcomes of failed drug tests or even misreport the results of the drug tests for some of the drugs that made it to market! That is scary. With all the money places like Eli Lily, Pfizer, and Merck pour into Research and Development, it is easy to imagine there would be significant financial pressure to sell their drugs. 

We are all subject to the ravages of depression, but please reconsider before taking a mind altering substance that could exacerbate your melancholy. Understand the big drug companies do not care about your mental health and are staffed with teams of litigators that will quash your lawsuit over harmful side effects. Jog, read, get a hobby. Figure out a way to NOT take pills when natural methods will help minimize the intensity of your depression.

Unreliable literature


The antidepressant controversy has highlighted the unreliability of scientific literature about the drugs-on which manufacturers rely to promote and defend their products and to oppose plaintiffs’ claims that antidepressants cause suicidal and violent behavior. Emerging evidence, in particular from editors of medical journals that publish the research, has revealed that the pharmaceutical industry has manipulated the results of research it funds, so much so that some reports published in medical journals barely resemble the underlying studies on which they are based.

In addition, studies that show a drug is effective are three times more likely to be published than those showing a drug doesn’t work or does more harm than good.Negative studies simply do not reach the journals. The studies that are published often are ghostwritten by the drug companies, listing the names of scientists considered leaders in their fields as the authors. Some contain marketing messages designed to maximize sales.

Facebooktwittergoogle_plusredditpinterestlinkedinmail

0 comments on “Unreliable Antidepressant drug literatureAdd yours →

Leave a Reply

Your email address will not be published. Required fields are marked *